Miguel Mínguez

4.2k total citations
126 papers, 2.2k citations indexed

About

Miguel Mínguez is a scholar working on Surgery, Gastroenterology and Genetics. According to data from OpenAlex, Miguel Mínguez has authored 126 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Surgery, 36 papers in Gastroenterology and 35 papers in Genetics. Recurrent topics in Miguel Mínguez's work include Inflammatory Bowel Disease (32 papers), Microscopic Colitis (27 papers) and Pelvic floor disorders treatments (24 papers). Miguel Mínguez is often cited by papers focused on Inflammatory Bowel Disease (32 papers), Microscopic Colitis (27 papers) and Pelvic floor disorders treatments (24 papers). Miguel Mínguez collaborates with scholars based in Spain, United States and Mexico. Miguel Mínguez's co-authors include A Benages, Vicente Sánchiz, Francisco Mora, Vicent Hernández, Pedro Almela, Belén Herreros, Marta Maia Boscá-Watts, R Añón, Eduardo García‐Granero and B. Herreros and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Miguel Mínguez

118 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miguel Mínguez Spain 24 1.2k 609 559 432 323 126 2.2k
Anthony J. DiMarino United States 29 1.3k 1.1× 970 1.6× 252 0.5× 219 0.5× 602 1.9× 97 2.6k
Norman S. Williams United Kingdom 30 2.1k 1.7× 640 1.1× 1.1k 2.0× 221 0.5× 192 0.6× 90 3.1k
J.M. Remes-Troche Mexico 28 1.6k 1.3× 1.4k 2.2× 594 1.1× 148 0.3× 428 1.3× 308 2.8k
Laurent Siproudhis France 34 2.4k 2.0× 466 0.8× 1.2k 2.2× 792 1.8× 680 2.1× 214 3.4k
Georges Coremans Belgium 27 2.1k 1.7× 1.2k 2.0× 334 0.6× 1.2k 2.7× 855 2.6× 87 3.2k
Anna Papadopoulou Greece 21 608 0.5× 182 0.3× 176 0.3× 171 0.4× 179 0.6× 89 2.1k
John M. DelGaudio United States 37 1.8k 1.5× 405 0.7× 137 0.2× 43 0.1× 312 1.0× 143 3.7k
Jukka Ronkainen Sweden 27 2.4k 1.9× 2.2k 3.7× 368 0.7× 84 0.2× 284 0.9× 51 3.2k
Gabriela Hernández‐Molina Mexico 23 789 0.6× 40 0.1× 1.2k 2.1× 144 0.3× 209 0.6× 114 2.3k
Yinon Shapira Israel 22 245 0.2× 168 0.3× 280 0.5× 207 0.5× 549 1.7× 70 1.8k

Countries citing papers authored by Miguel Mínguez

Since Specialization
Citations

This map shows the geographic impact of Miguel Mínguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel Mínguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel Mínguez more than expected).

Fields of papers citing papers by Miguel Mínguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miguel Mínguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel Mínguez. The network helps show where Miguel Mínguez may publish in the future.

Co-authorship network of co-authors of Miguel Mínguez

This figure shows the co-authorship network connecting the top 25 collaborators of Miguel Mínguez. A scholar is included among the top collaborators of Miguel Mínguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel Mínguez. Miguel Mínguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martí‐Aguado, David, María Pilar Ballester, & Miguel Mínguez. (2021). Risk factors and management strategies associated with non-response to aminosalicylates for maintenance treatment in ulcerative colitis. Revista Española de Enfermedades Digestivas. 113(6). 447–453. 9 indexed citations
2.
Casellas, Francesc, et al.. (2021). Factors associated with quality of care in inflammatory bowel diseases: a view from patient’s side using the IQCARO quality of care decalogue. BMC Gastroenterology. 21(1). 412–412. 5 indexed citations
3.
Boscá-Watts, Marta Maia, Rafael Alós, Nuria Maroto, et al.. (2020). Recommendations of the Crohn’s Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn’s disease. Gastroenterología y Hepatología (English Edition). 43(3). 155–168. 8 indexed citations
4.
Boscá-Watts, Marta Maia, Miguel Mínguez, Dolores Planelles, et al.. (2018). HLA-DQ: Celiac diseasevsinflammatory bowel disease. World Journal of Gastroenterology. 24(1). 96–103. 14 indexed citations
5.
Iborra, Marisa, Belén Beltrán, Nuria Maroto, et al.. (2018). Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents. Gastroenterología y Hepatología (English Edition). 41(9). 535–543. 1 indexed citations
6.
McClafferty, Julie, Miguel Mínguez, Youjia Fang, Feng Guo, & Thomas A. Dingus. (2018). Prevalence of Drowsy Driving Crashes: Estimates from a Large-Scale Naturalistic Driving Study. 54 indexed citations
7.
8.
Gisbert, Javier P., Manuel Barreiro‐de Acosta, María Esteve, et al.. (2015). Physician Perspectives on Unresolved Issues in the Management of Ulcerative Colitis. Inflammatory Bowel Diseases. 22(3). 583–598.
9.
Hernández, Vicent, María Miranda, Isabel Pascual, et al.. (2011). Malondialdehyde in early phase of acute pancreatitis. Revista Española de Enfermedades Digestivas. 103(11). 563–569. 14 indexed citations
10.
Mínguez, Miguel, et al.. (2009). Escala de Bristol: ¿un sistema útil para valorar la forma de las heces?. Revista Española de Enfermedades Digestivas. 101(5). 20 indexed citations
11.
Gil‐Benso, Rosario, Vicent Quilis-Quesada, Miguel Mínguez, et al.. (2009). Primary glioblastomas with and without EGFR amplification: Relationship to genetic alterations and clinicopathological features. Neuropathology. 30(4). 392–400. 34 indexed citations
12.
Perona, Mónica, Fermín Mearin, M. Guilera, et al.. (2008). Cuestionario específico de calidad de vida para pacientes con estreñimiento: desarrollo y validación del CVE-20. Medicina Clínica. 131(10). 371–377. 6 indexed citations
13.
Ibáñez, Berta, Miguel Mínguez, Manel Poch, et al.. (2007). Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models. RNA. 13(5). 756–762. 42 indexed citations
14.
Boscá-Watts, Marta Maia, et al.. (2007). Aproximación diagnóstica y terapéutica al paciente con gastroparesia. Gastroenterología y Hepatología. 30(6). 351–359. 3 indexed citations
15.
Uribe, Natalia, et al.. (2006). Clinical and manometric results of endorectal advancement flaps for complex anal fistula. International Journal of Colorectal Disease. 22(3). 259–264. 76 indexed citations
16.
Mínguez, Miguel & A Benages. (2003). Tratamiento del estreñimiento crónico en situaciones especiales. 2(4). 140–142. 1 indexed citations
17.
Mínguez, Miguel, Belén Herreros, & A Benages. (2003). Chronic anal fissure. Current Treatment Options in Gastroenterology. 6(3). 257–262. 9 indexed citations
18.
Mir, A., Miguel Mínguez, Isabel Pascual, et al.. (2002). Elevated serum eotaxin levels in patients with inflammatory bowel disease. The American Journal of Gastroenterology. 97(6). 1452–1457. 63 indexed citations
19.
Mínguez, Miguel, et al.. (1999). Criterios diagnósticos de reservoritis tras proctocolectomía restauradora por colitis ulcerosa. Cirugía Española. 65(4). 292–296.
20.
Mínguez, Miguel, Francisco Tiago de Vasconcelos Melo, Alejandro Espí, et al.. (1999). Therapeutic effects of different doses of botulinum toxin in chronic anal fissure. Diseases of the Colon & Rectum. 42(8). 1016–1021. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony J. DiMarino Breakdown of academic impact, for papers by Norman S. Williams Breakdown of academic impact, for papers by J.M. Remes-Troche Breakdown of academic impact, for papers by Laurent Siproudhis Breakdown of academic impact, for papers by Georges Coremans Breakdown of academic impact, for papers by Anna Papadopoulou Breakdown of academic impact, for papers by John M. DelGaudio Breakdown of academic impact, for papers by Jukka Ronkainen Breakdown of academic impact, for papers by Gabriela Hernández‐Molina Breakdown of academic impact, for papers by Yinon Shapira
Rankless by CCL
2026